Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

How Medicare Advantage Insurers Will Be Affected By Proposed 2024 Payment Cut

Published 02/02/2023, 21:43
Updated 02/02/2023, 23:10
© Reuters.  How Medicare Advantage Insurers Will Be Affected By Proposed 2024 Payment Cut

Benzinga - Medicare Advantage insurers might see an average 2.27% reduction in baseline payments in 2024, the Centers for Medicare and Medicaid Services said Wednesday. If the idea is approved, according to StatNews, the industry will see a net loss of more than $3 billion.

What Happened: Medicare authorities are seeking to update data and coding methods that are used to describe the health conditions of an insurance company's enrollees, which is the rationale behind the proposed pay cut. Insurance companies would not generate as much revenue from members with certain diagnoses under that new approach.

Insurers including CVS Health Corp (NYSE: CVS), UnitedHealth Group Inc (NYSE: UNH), Cigna Corp (NYSE: CI), Humana Inc (NYSE: HUM), and others are affected by the proposal.

The proposed cut compares to a 5% increase (4.48% proposed) in last year's rulemaking process, Oppenheimer & Co said in an industry note Wednesday, and a 3.3% average increase over the last five years.

The plan comprises a 2.09% core rate hike, a negative 3.12% normalization factor, and an anticipated negative 1.24% Star Ratings-related decrease.

The majority of plans saw a decrease in star ratings as a result of the COVID-era hold harmless provisions' expiration in 2021/2022. This will vary by insurer.

In the previous five years, rates in the sector averaged 3.3%. Prior to those five years, however, the sector managed with growth below that level successfully. The increases between 2016 and 2018 were 0.85% on average.

Photo via Shutterstock.

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.